Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO,
branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein …

Yellow subthreshold micropulse laser (YSML) is a retinal laser capable of inducing a
biologic response without causing thermal damage to the targeted tissue. The 577-nm …

Background: Retinal vein occlusion (RVO) occurs when there is partial or complete
obstruction of a retinal vein, and it is classified by the location of the occlusion. An …

The ocular vasculature is critically involved in many blinding diseases and is also a popular
research model for the exploration of developmental and pathological angiogenesis. The …

Retinal vein occlusion (RVO) is the second most common retinal vascular disorder following
diabetic retinopathy and is often associated with vision loss. 4 Retinal vein occlusion occurs …

Aims Branch retinal vein occlusion (BRVO) leads to extensive vascular remodeling and is
important cause of visual impairment. Although the vascular morphological changes …

Purpose To elucidate the current clinical practice patterns of branch retinal vein occlusion
(BRVO) management by retina specialists in Japan in the era of anti-vascular endothelial …

Purpose: To report the outcomes of pars plana vitrectomy (PPV) for vitreous hemorrhage
(VH) associated with retinal vein occlusion (RVO) and to identify prognostic indicators …

Purpose To systematically review the published manuscripts on the non-steroidal intravitreal
injection for treatment of noninfectious uveitic cystoid macular edema (CME). Methods The …

Purpose. To present the case of a 27‐year‐old male patient with stage IV proliferative sickle
cell retinopathy, treated with one intravitreal injection of ranibizumab, showing regression of …